Reversible Cerebellar Leukoencephalopathy Associated With Oral Methotrexate
Journal of the Korean Neurological Association
; : 168-170, 2014.
Article
in Ko
| WPRIM
| ID: wpr-27585
Responsible library:
WPRO
ABSTRACT
Methotrexate (MTX)-induced leukoencephalopathy is the most often reported leukoencephalopathy following intrathecal or intravenous administration. A 72-year-old woman developed leukoencephalopathy localized to the cerebellum after treatment with oral MTX at a dose of 15 mg/week for 3 years. She complained of subtle imbalance during walking and reported having fallen. Her symptoms improved after discontinuation of MTX, and the leukoencephalopathy resolved. This is therefore a case report of selective cerebellar reversible leukoencephalopathy associated with oral MTX.
Key words
Full text:
1
Database:
WPRIM
Main subject:
Cerebellum
/
Methotrexate
/
Walking
/
Leukoencephalopathies
/
Administration, Intravenous
Limits:
Aged
/
Female
/
Humans
Language:
Ko
Journal:
Journal of the Korean Neurological Association
Year:
2014
Document type:
Article